3,5-Pyridinedicarboxylic acid, 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-, 3-methyl 5-[(1-oxobutoxy)methyl] ester
| Title | Journal |
|---|---|
| Differential modulation of FXR activity by chlorophacinone and ivermectin analogs. | Toxicology and applied pharmacology 20161215 |
| Pharmacokinetics, pharmacodynamics, and safety of clevidipine after prolonged continuous infusion in subjects with mild to moderate essential hypertension. | European journal of clinical pharmacology 20121001 |
| Perioperative management of pheochromocytoma: focus on magnesium, clevidipine, and vasopressin. | Journal of cardiothoracic and vascular anesthesia 20120601 |
| Intraoperative administration of clevidipine to prevent vasospasm after radial and internal mammary artery grafts during coronary artery bypass grafting. | American journal of therapeutics 20120501 |
| Clevidipine : a state-of-the-art antihypertensive drug under the scope. | Expert opinion on pharmacotherapy 20120201 |
| Clevidipine for controlled hypotension during spinal surgery in adolescents. | Journal of neurosurgical anesthesiology 20111001 |
| Clevidipine for controlled hypotension during spinal surgery in adolescents. | Middle East journal of anaesthesiology 20110601 |
| Clevidipine for severe hypertension in patients with renal dysfunction: a VELOCITY trial analysis. | Blood pressure. Supplement 20110401 |
| Perioperative blood pressure management: walking a tightrope. | Annals of cardiac anaesthesia 20110101 |
| Cardiovascular pharmacology: an update. | Anesthesiology clinics 20101201 |
| Efficacy of clevidipine in controlling perioperative hypertension in neurosurgical patients: initial single-center experience. | Journal of neurosurgical anesthesiology 20101001 |
| Use of clevidipine for intraoperative hypertension caused by an undiagnosed pheochromocytoma: a case report. | AANA journal 20100801 |
| Clevidipine: a short-acting intravenous dihydropyridine calcium channel blocker for the management of hypertension. | Pharmacotherapy 20100501 |
| Clevidipine: a new intravenous option for the management of acute hypertension. | American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20100301 |
| Clevidipine butyrate: a promising new drug for the management of acute hypertension. | Expert opinion on pharmacotherapy 20100201 |
| Parenteral nutrition in the critically ill patient. | The New England journal of medicine 20100107 |
| Clevidipine for the treatment of severe hypertension in adults. | Clinical therapeutics 20100101 |
| Clevidipine for severe hypertension in acute heart failure: a VELOCITY trial analysis. | Congestive heart failure (Greenwich, Conn.) 20100101 |
| Role of clevidipine butyrate in the treatment of acute hypertension in the critical care setting: a review. | Vascular health and risk management 20100101 |
| Preliminary experience with clevidipine in the pediatric population. | Journal of intensive care medicine 20100101 |
| Clevidipine, an intravenous dihydropyridine calcium channel blocker, is safe and effective for treatment of patients with acute severe hypertension answers to the march 2009 journal club questions. | Annals of emergency medicine 20090801 |
| A new intravenous calcium channel blocker option to treat acute elevations in blood pressure. | Journal of clinical hypertension (Greenwich, Conn.) 20090701 |
| Clevidipine: an ultra short-acting calcium channel antagonist for acute hypertension. | The Annals of pharmacotherapy 20090701 |
| New drugs 09, part 2. | Nursing 20090601 |
| Clevidipine in the treatment of perioperative hypertension: assessing safety events in the ECLIPSE trials. | Expert review of cardiovascular therapy 20090501 |
| Clevidipine, an intravenous dihydropyridine calcium channel blocker, is safe and effective for the treatment of patients with acute severe hypertension. | Annals of emergency medicine 20090301 |
| Clevidipine: a review of its use in the management of acute hypertension. | American journal of cardiovascular drugs : drugs, devices, and other interventions 20090101 |
| Clevidipine: a novel ultra-short-acting calcium antagonist. | Cardiology in review 20090101 |
| Drug evaluation of clevidipine for acute hypertension. | Expert opinion on pharmacotherapy 20081001 |
| The ECLIPSE trials: comparative studies of clevidipine to nitroglycerin, sodium nitroprusside, and nicardipine for acute hypertension treatment in cardiac surgery patients. | Anesthesia and analgesia 20081001 |
| Novel I.V. drug approved. | Nursing 20081001 |
| Clevidipine (Cleviprex) for IV treatment of severe hypertension. | The Medical letter on drugs and therapeutics 20080922 |
| FDA approves i.v. calcium-channel blocker. | American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20080915 |
| Treatment of acute postoperative hypertension in cardiac surgery patients: an efficacy study of clevidipine assessing its postoperative antihypertensive effect in cardiac surgery-2 (ESCAPE-2), a randomized, double-blind, placebo-controlled trial. | Anesthesia and analgesia 20080701 |
| Perioperative hypertension management. | Vascular health and risk management 20080601 |
| New drugs: Clevidipine butyrate, difluprednate, and tetrabenazine. | Journal of the American Pharmacists Association : JAPhA 20080101 |
| Clevidipine effectively and rapidly controls blood pressure preoperatively in cardiac surgery patients: the results of the randomized, placebo-controlled efficacy study of clevidipine assessing its preoperative antihypertensive effect in cardiac surgery-1. | Anesthesia and analgesia 20071001 |
| New therapeutic perspectives with clevidipine: an ultra-short-acting intravenous Ca2+ channel blocker. | Expert opinion on investigational drugs 20070901 |
| New drugs for hypertension: what do they offer? | Current hypertension reports 20061001 |
| Human cytochrome p450 induction and inhibition potential of clevidipine and its primary metabolite h152/81. | Drug metabolism and disposition: the biological fate of chemicals 20060501 |
| Current diagnosis and management of hypertensive emergency. | Seminars in dialysis 20060101 |
| Failure to demonstrate myocardial protective effects of the ultra short-acting calcium antagonist clevidipine in a closed-chest reperfusion porcine model. | Journal of cardiovascular pharmacology 20041001 |
| Pharmacodynamic, pharmacokinetic and clinical effects of clevidipine, an ultrashort-acting calcium antagonist for rapid blood pressure control. | Cardiovascular drug reviews 20040101 |
| Comparison of clevidipine with sodium nitroprusside in the control of blood pressure after coronary artery surgery. | European journal of anaesthesiology 20030901 |
| Cardiac sympathetic nerve stimulation triggers coronary t-PA release. | Arteriosclerosis, thrombosis, and vascular biology 20030601 |
| Calcium antagonist clevidipine reduces myocardial reperfusion injury by a mechanism related to bradykinin and nitric oxide. | Journal of cardiovascular pharmacology 20021001 |
| Clevidipine (the Medicines Company). | Current opinion in investigational drugs (London, England : 2000) 20021001 |
| Time-dependent cardioprotection with calcium antagonism and experimental studies with clevidipine in ischemic-reperfused pig hearts: part II. | Journal of cardiovascular pharmacology 20020901 |
| Time-dependent cardioprotection with calcium antagonism and experimental studies with clevidipine in ischemic-reperfused pig hearts: part I. | Journal of cardiovascular pharmacology 20020801 |
| Clevidipine in adult cardiac surgical patients: a dose-finding study. | Anesthesiology 20020501 |
| Effects of fenoldopam, a dopamine D-1 agonist, and clevidipine, a calcium channel antagonist, in acute renal failure in anesthetized rats. | Clinical and experimental hypertension (New York, N.Y. : 1993) 20020501 |
| Clevidipine. | Drugs in R&D 20020101 |
| Short-acting calcium antagonist clevidipine protects against reperfusion injury via local nitric oxide-related mechanisms in the jeopardised myocardium. | Cardiovascular research 20010701 |
| Fast enantioselective separation of clevidipine and a dihydropyridine substituted acid by SFC on Chiralpak AD. | Fresenius' journal of analytical chemistry 20010101 |
| Enantioselective pharmacokinetics of the enantiomers of clevidipine following intravenous infusion of the racemate in essential hypertensive patients. | Chirality 20010101 |